ReachMD

Be part of the knowledge.™

Diabetes and Endocrinology

1235

LikeLikedUnlike

Episodes 1-15 of 362

- Carol Wysham, MD
  Peer
- Irl Hirsch, MD, MACP
  Peer
3
Diabetes Discourse
Improving Diabetes Care with Technology: A Look at Continuous Glucose Monitors
Improving Diabetes Care with Technology: A Look at Continuous Glucose Monitors
- Carol Wysham, MD
  Peer
- Irl Hirsch, MD, MACP
  Peer
4
Diabetes Discourse
Discovering the Discordance Between Measured A1Cs & GMIs
Discovering the Discordance Between Measured A1Cs & GMIs
- John Buse, MD, PhD
  Peer
- Anne Louise Peters, MD
  Peer
0
Diabetes Discourse
Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation
Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation
- Hector O. Chapa, MD
  Peer
- Andrew Little, DO
  Peer
0
Vascular Viewpoints
An Intraosseous Inspection: Using IO Devices for Vascular Access
An Intraosseous Inspection: Using IO Devices for Vascular Access
- John Buse, MD, PhD
  Peer
0
Diabetes Discourse
A Wake-Up Call to Diabetes: Spreading Awareness of Its Seriousness
A Wake-Up Call to Diabetes: Spreading Awareness of Its Seriousness
- John Buse, MD, PhD
  Peer
0
Diabetes Discourse
When & How to Screen Patients for Diabetes
When & How to Screen Patients for Diabetes
- John E. Anderson, MD
  Peer
- Matthias Hebrok, PhD
  Peer
3
Diabetes Discourse
Exploring Stem Cell Research & Novel Options in Type 1 Diabetes
Exploring Stem Cell Research & Novel Options in Type 1 Diabetes
- John Buse, MD, PhD
  Peer
- Antonios Douros, MD
  Peer
5
Diabetes Discourse
Diving into Diabetes: Investigating SGLT2 Inhibitors & Diabetic Ketoacidosis
Diving into Diabetes: Investigating SGLT2 Inhibitors & Diabetic Ketoacidosis
- John E. Anderson, MD
  Peer
- Matthias Hebrok, PhD
  Peer
3
Diabetes Discourse
Investigating Type 1 Diabetes & Its Chronic Impacts
Investigating Type 1 Diabetes & Its Chronic Impacts
- Carol Wysham, MD
  Peer
- Alexis Markey McKee, MD
  Peer
3
Diabetes Discourse
Managing Diabetes During the COVID-19 Pandemic
Managing Diabetes During the COVID-19 Pandemic
- John Buse, MD, PhD
  Peer
- David Wheeler, MB, CHB, MD, FRCP
  Peer
4
Diabetes Discourse
Understanding Dapagliflozin: Examining Its Use in Chronic Kidney Disease
Understanding Dapagliflozin: Examining Its Use in Chronic Kidney Disease
- Carol Wysham, MD
  Peer
- Janet B. McGill, MD, MA, FACE, FACP
  Peer
5
Diabetes Discourse
Assessing Atypical Diabetes: Detection & Diagnosis
Assessing Atypical Diabetes: Detection & Diagnosis
- Matthew J. Sorrentino, MD, FACC, FASH
  Peer
- Alan S. Brown, MD, FACC, FAHA, FNLA
  Peer
13
Heart Matters
Detecting & Diagnosing Diabetes in Cardiology Patients
Detecting & Diagnosing Diabetes in Cardiology Patients
- Janet B. McGill, MD, MA, FACE, FACP
  Peer
- John J. Russell, MD
  Peer
13
CME/CE
At the Crossroad of Care: New Advances in Diabetic Kidney Disease
At the Crossroad of Care: New Advances in Diabetic Kidney Disease
0.50 credits
- John E. Anderson, MD
  Peer
- Jason Sloane, MD
  Peer
2
Diabetes Discourse
Highlighting a Hero in Endocrinology: Dr. Jason Sloane
Highlighting a Hero in Endocrinology: Dr. Jason Sloane

Programs 4/16/21

Segment Chapters

Playlist:

Recommended